120 related articles for article (PubMed ID: 31702399)
21. Enterobacter sakazakii: an emerging pathogen in infants and neonates.
Hunter CJ; Petrosyan M; Ford HR; Prasadarao NV
Surg Infect (Larchmt); 2008 Oct; 9(5):533-9. PubMed ID: 18687047
[TBL] [Abstract][Full Text] [Related]
22. Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by lactoferrin.
Quintero-Villegas MI; Wittke A; Hutkins R
Curr Microbiol; 2014 Oct; 69(4):574-9. PubMed ID: 24928110
[TBL] [Abstract][Full Text] [Related]
23. A Role for cAMP and Protein Kinase A in Experimental Necrotizing Enterocolitis.
Blackwood BP; Wood DR; Yuan C; Nicolas J; De Plaen IG; Farrow KN; Chou P; Turner JR; Hunter CJ
Am J Pathol; 2017 Feb; 187(2):401-417. PubMed ID: 27939131
[TBL] [Abstract][Full Text] [Related]
24. Caenorhabditis elegans as a model for studying Cronobacter sakazakii ATCC BAA-894 pathogenesis.
Sivamaruthi BS; Ganguli A; Kumar M; Bhaviya S; Pandian SK; Balamurugan K
J Basic Microbiol; 2011 Oct; 51(5):540-9. PubMed ID: 21656805
[TBL] [Abstract][Full Text] [Related]
25. [Enterobacter sakazakii in powdered infant formula].
Friedemann M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jun; 51(6):664-74. PubMed ID: 18465099
[TBL] [Abstract][Full Text] [Related]
26. ROCK1 inhibitor stabilizes E-cadherin and improves barrier function in experimental necrotizing enterocolitis.
Buonpane C; Yuan C; Wood D; Ares G; Klonoski SC; Hunter CJ
Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G781-G792. PubMed ID: 32090605
[TBL] [Abstract][Full Text] [Related]
27. Comparison of virulence of three strains of Cronobacter sakazakii in neonatal CD-1 mice.
Richardson AN; Beuchat LR; Lambert S; Williams D; Smith MA
J Food Prot; 2010 May; 73(5):849-54. PubMed ID: 20501035
[TBL] [Abstract][Full Text] [Related]
28. Influence of sweet whey protein concentrate and its hydrolysates on host-pathogen interactions in the emerging foodborne pathogen Cronobacter sakazakii.
McEvoy K; Hayes J; Kealey C; Brady D
J Appl Microbiol; 2016 Sep; 121(3):873-82. PubMed ID: 27337492
[TBL] [Abstract][Full Text] [Related]
29. CpxAR two-component system contributes to virulence properties of Cronobacter sakazakii.
Jin T; Zhan X; Pang L; Peng B; Zhang X; Zhu W; Yang B; Xia X
Food Microbiol; 2024 Feb; 117():104393. PubMed ID: 37919015
[TBL] [Abstract][Full Text] [Related]
30. Proteomic analysis of the mode of antibacterial action of trans-cinnamaldehyde against Cronobacter sakazakii 415.
Amalaradjou MA; Venkitanarayanan K
Foodborne Pathog Dis; 2011 Oct; 8(10):1095-102. PubMed ID: 21682589
[TBL] [Abstract][Full Text] [Related]
31. Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by prebiotic oligosaccharides.
Quintero M; Maldonado M; Perez-Munoz M; Jimenez R; Fangman T; Rupnow J; Wittke A; Russell M; Hutkins R
Curr Microbiol; 2011 May; 62(5):1448-54. PubMed ID: 21293857
[TBL] [Abstract][Full Text] [Related]
32. High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod.
Zamora R; Grishin A; Wong C; Boyle P; Wang J; Hackam D; Upperman JS; Tracey KJ; Ford HR
Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G643-52. PubMed ID: 15947118
[TBL] [Abstract][Full Text] [Related]
33. RNA Sequencing-Based Transcriptional Overview of Xerotolerance in Cronobacter sakazakii SP291.
Srikumar S; Cao Y; Yan Q; Van Hoorde K; Nguyen S; Cooney S; Gopinath GR; Tall BD; Sivasankaran SK; Lehner A; Stephan R; Fanning S
Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30446557
[No Abstract] [Full Text] [Related]
34. Antibacterial activities of plant-derived compounds and essential oils toward Cronobacter sakazakii and Cronobacter malonaticus.
Fraňková A; Marounek M; Mozrová V; Weber J; Klouček P; Lukešová D
Foodborne Pathog Dis; 2014 Oct; 11(10):795-7. PubMed ID: 25062020
[TBL] [Abstract][Full Text] [Related]
35. Development of a loop-mediated isothermal amplification assay for sensitive and rapid detection of Cronobacter sakazakii.
Fan H; Long B; Wu X; Bai Y
Foodborne Pathog Dis; 2012 Dec; 9(12):1111-8. PubMed ID: 23199494
[TBL] [Abstract][Full Text] [Related]
36. Maternal N-acetyl-cysteine prevents neonatal brain injury associated with necrotizing enterocolitis in a rat model.
Zmora O; Gutzeit O; Segal L; Boulos S; Millo Z; Ginsberg Y; Khatib N; Fainaru O; Ross MG; Weiner Z; Beloosesky R
Acta Obstet Gynecol Scand; 2021 May; 100(5):979-987. PubMed ID: 33247942
[TBL] [Abstract][Full Text] [Related]
37. Development of Bioluminescent Cronobacter sakazakii ATCC 29544 in a Mouse Model.
Wang X; Li Z; Dong X; Chi H; Wang G; Li J; Sun R; Chen M; Zhang X; Wang Y; Qu H; Sun Y; Xia Z; Li Q
J Food Prot; 2015 May; 78(5):1007-12. PubMed ID: 25951398
[TBL] [Abstract][Full Text] [Related]
38. Protective Effect of Recombinant Proteins of
Song JR; Fu YW; Li P; Du T; Du XJ; Wang S
Front Cell Infect Microbiol; 2020; 10():15. PubMed ID: 32076598
[No Abstract] [Full Text] [Related]
39. The Protective Effect of Sulforaphane on ER-induced Apoptosis and Inflammation in Necrotizing Enterocolitis Mice.
Wang X; Mi Y; Xiong X; Bao Z
Comb Chem High Throughput Screen; 2023; 26(6):1186-1195. PubMed ID: 35792122
[TBL] [Abstract][Full Text] [Related]
40. Cronobacter sakazakii clinical isolates overcome host barriers and evade the immune response.
Almajed FS; Forsythe SJ
Microb Pathog; 2016 Jan; 90():55-63. PubMed ID: 26616163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
